Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy

被引:6
|
作者
Zhou, M [1 ]
Hayasaka, S
Taylor, JMG
Shah, R
Proverbs-Singh, T
Manley, S
Rubin, MA
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Urol Sect, Ann Arbor, MI USA
关键词
prostate; prostatic neoplasms; prostate-specific antigen; prostatectomy;
D O I
10.1016/S0022-5347(05)65533-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Grading prostate cancer using the Gleason system relies only on architectural tumor growth, in contrast to other systems, such as the WHO system, which grade prostate carcinoma based on nuclear features as well as architectural patterns. The prognostic significance of nuclear grading remains controversial since most studies were performed before prostate specific antigen (PSA) screening became widely available. We evaluated the significance of nuclear grade for predicting PSA recurrence in a contemporary cohort of patients treated with radical prostatectomy for clinically localized prostate carcinoma. Materials and Methods: Nuclear grades 1 to 3 were determined in 141 consecutive radical prostatectomies in 1995. Predominant and worst nuclear grade was determined by a consensus of 3 pathologists. Statistical analysis compared nuclear grade with Gleason score using the chi-square test. The Cox proportional hazards analysis was performed to calculate the ability of nuclear grade, Gleason score and other variables to predict PSA recurrence. Results: We identified a significant association of Gleason score with worst nuclear grade (p = 0.007). All 6 cases with a Gleason score of 8 or greater had a worst nuclear grade of 3, in contrast to 36 of 60 (60%) with a score 6 or less, in which the worst nuclear grade was 3. Of the 141 patients 31 (21.9%) had PSA recurrence at a median followup of 3.7 years. The univariate Cox model revealed significant associations of PSA recurrence with Gleason score 8 or greater (hazards ratio 5.5, p = 0.005), extraprostatic extension (hazards ratio 3.4, p = 0.001), positive surgical margin (hazards ratio 2.6, p = 0.009), seminal vesicle involvement (hazards ratio 7.3, p <0.001), preoperative serum PSA (hazards ratio 1.03, p = 0.007), tumor stage (hazards ratio 3.6, p = 0.001) and maximal tumor dimension (:hazards ratio 2.4, p <0.001). However, overall and worst nuclear grade did not predict PSA recurrence (p = 0.89 and 0.13, respectively). Nuclear grade did not fit any multivariate model tested, which otherwise included Gleason score, log(PSA), surgical margin status, extraprostatic extension, seminal vesicle status, tumor size and pathological stage. By varying sample fixation time we also showed that benign prostate tissue in the same section as prostate carcinoma had grade 2 or 3 nuclear changes, that is moderate to marked anaplasia. Conclusions: High nuclear grade is associated with high Gleason score. However, prostate carcinoma with a Gleason score of 6 or less shows extreme variability. Nuclear grade determined by light microscopy failed to predict PSA recurrence in a contemporary series of men with clinically localized prostate cancer treated with radical prostatectomy. Nuclear morphology is subject to tissue fixation and processing artifact. Any nuclear morphometric study must consider this artifact.
引用
收藏
页码:2193 / 2197
页数:5
相关论文
共 50 条
  • [41] Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence
    Marks, Rebecca A.
    Lin, Haiqun
    Koch, Michael O.
    Cheng, Liang
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (06) : 877 - 881
  • [42] Prostate Specific Antigen Density to Predict Prostate Cancer Upgrading in a Contemporary Radical Prostatectomy Series: A Single Center Experience
    Magheli, Ahmed
    Hinz, Stefan
    Hege, Claudia
    Stephan, Carsten
    Jung, Klaus
    Miller, Kurt
    Lein, Michael
    JOURNAL OF UROLOGY, 2010, 183 (01) : 126 - 131
  • [43] Hazard of Prostate Cancer Specific Mortality After Radical Prostatectomy
    Shikanov, Sergey
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2012, 187 (01) : 124 - 127
  • [44] 25-Year Disease-Free Survival Rate After Irradiation for Prostate Cancer Calculated with the Prostate Specific Antigen Definition of Recurrence Used for Radical Prostatectomy
    Critz, Frank A.
    Benton, James B.
    Shrake, Philip
    Merlin, Mark L.
    JOURNAL OF UROLOGY, 2013, 189 (03) : 878 - 883
  • [45] Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy
    Joung, Jae Young
    Cho, Kang Su
    Chung, Han Soo
    Cho, In-Chang
    Kim, Jung Eun
    Seo, Ho Kyung
    Chung, Jinsoo
    Park, Weon Seo
    Choi, Moon Kyung
    Lee, Kang Hyun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (09) : 1291 - 1295
  • [46] The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy
    vanIersel, MP
    Thomas, CMG
    Segers, MFC
    Witjes, WPJ
    Debruyne, FMJ
    Oosterhof, GON
    BRITISH JOURNAL OF UROLOGY, 1996, 77 (03): : 418 - 422
  • [47] Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy
    Hamilton, Robert J.
    Aronson, William J.
    Presti, Joseph C., Jr.
    Terris, Martha K.
    Kane, Christopher J.
    Amling, Christopher L.
    Freedland, Stephen J.
    CANCER, 2007, 110 (10) : 2202 - 2209
  • [48] Body Mass Index and Prostate Specific Antigen as Predictors of Adverse Pathology and Biochemical Recurrence After Prostatectomy
    Banez, Lionel L.
    Sun, Leon
    Trock, Bruce J.
    Han, Misop
    Partin, Alan W.
    Aronson, William J.
    Terris, Martha K.
    Presti, Joseph C., Jr.
    Kane, Christopher J.
    Amling, Christopher L.
    Moul, Judd W.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2009, 182 (02) : 491 - 496
  • [49] Radical prostatectomy for prostate cancer patients with prostate-specific antigen &gt;20 ng/ml
    Ou, YC
    Chen, JT
    Cheng, CL
    Ho, HC
    Yang, CR
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 574 - 579
  • [50] Prostate Specific Antigen at the Initial Diagnosis of Metastasis to Bone in Patients After Radical Prostatectomy
    Loeb, Stacy
    Makarov, Danil V.
    Schaeffer, Edward M.
    Humphreys, Elizabeth B.
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 184 (01) : 157 - 161